All cholera articles
-
NewsImproved oral cholera vaccine achieves WHO PQ
EuBiologics and the International Vaccine Institute (IVI) announced that Euvichol-S, an improved oral cholera vaccine (OCV) developed jointly by EuBiologics and IVI, has achieved World Health Organization prequalification.
-
NewsIVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
NewsAntibiotics highjack bacterial immunity
Molecular defense system protects bacteria from viruses and at the same time makes them susceptible to antibiotics.
-
NewsSimplified formulation of oral cholera vaccine, licensed by Korean regulatory agency
Euvichol-S, a simplified formulation of oral cholera vaccine, has been licensed by Korean regulatory agency, and is expected to alleviate global cholera vaccine shortages.
-
NewsDr Thomas Thompson named as winner of inaugural John Snow Prize
Dr Thomas Thompson of Queen’s University Belfast in Northern Ireland has been named as this year’s winner of the inaugural John Snow Prize for microbiology. The prize is part of the Applied Microbiology International Horizon Awards, which celebrate the brightest minds in the field and promote the ...
-
NewsResearchers discover new method to inhibit cholera infection
A new study investigates a novel strategy for inhibiting the spread and infection of Vibrio cholerae, the bacteria responsible for the disease cholera.
-
NewsGenes fuelling antibiotic resistance in Yemen cholera outbreak uncovered
Widespread antibiotic resistance among cholera-causing bacteria causing the outbreak in Yemen since 2018 explained by gene mixing.
-
NewsCholera-like bacteria may be crucial in development of new antibiotics
Researchers have produced a reconstructed version of the PomAB motor protein complex in a bacterium called Vibrio alginolyticus that resembles the cholera bacterium.
-
NewsNew cholera substrains in Bangladesh uncovered by genomic surveillance
Researchers have uncovered two new cholera substrains in a displaced refugee population in southern Bangladesh, where a pre-emptive mass vaccination campaign of over one million refugees was successful in preventing an epidemic.
-
NewsD-amino acids play role in cholera bacterium’s bid to escape
Cholera bacteria use specific D-amino acids to escape unfavourable niches and form complex ecological systems, a new study shows.
-
NewsCholera bacteria form aggressive biofilm to kill immune cells
Resarchers have discovered that the bacterial pathogen that causes cholera forms a novel type of bacterial community on immune cells: an aggressive biofilm that is lethal for the cells.
-
NewsMolecules found in mucus could prevent cholera infection
MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause the microbe to switch into a harmful state.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
